News – Page 278
-
NewsInjured postdoc sues University of Hawaii over lab explosion
Researcher received dangerous research equipment and requests for safety training were ignored, her lawyers argue
-
ResearchWastewater plant upgrade fixes fish feminisation problem
Gender balance has been restored in a Canadian river by cutting levels of endocrine disruptors
-
NewsMark Walport named as new head of UKRI
Chief scientific adviser will lead UK’s new research organisation
-
NewsWomen in science and engineering representation varies widely by field
Of nearly 23,000 US graduate students in chemistry in 2014, roughly 8200 were full-time female students, latest figures reveals
-
BusinessSabic takes control of Shell petrochemicals joint venture
$820m sale of Saudi Arabian plants continues Shell’s global reorganisation programme
-
NewsFears for fundamental science after India's latest budget
Narendra Modi’s promise to make India a global science power not backed up by funding boost
-
ResearchMolecular structure is teixobactin’s pièce de résistance
Study builds scientists’ arsenal against drug-resistant superbugs
-
NewsAlzheimer’s disease: have drug developers been on the wrong track?
Dementia drug developers urged to look beyond amyloid
-
NewsUniversity fined in caffeine overdose case
Students given 100 times more caffeine than intended as a result of potentially lethal miscalculation
-
ResearchNon-Newtonian saliva gives frog’s tongue sticking power
Discovery offers route to frog-inspired adhesives
-
BusinessLilly buys CoLucid for migraine drugs
US firm also laying off 485 sales staff after Alzheimer’s drug failure
-
BusinessMerck & Co settles cancer antibody patent dispute
US firm will pay Bristol-Myers Squibb and Ono $625m plus royalties on future sales of immunotherapy
-
BusinessTeva hit with fines and patent loss
Double whammy as firm settles subsidiary pay-for-delay suit and courts invalidate patents on multiple sclerosis drug
-
ResearchUnusual metathesis catalyst holds stereoselectivity promise
Molybdenum catalyst can make Z -trifluoromethyl-substituted olefins useful for pharmaceuticals, agrochemicals and materials
-
-
BusinessJ&J to buy Actelion for $30bn
Actelion’s R&D will spin out as a new company, while Janssen will take on in-market and late-stage medicines
-
NewsTrump immigration edict disrupts American science
Ninety-day bar on citizens from seven Muslim majority nations blocks entry of students and scientists
-
NewsScientists condemn UK plan to leave European nuclear agency
Leaving Euratom could ruin international research projects and hold up nuclear power plant development
-
BusinessBiogen pays $1.25bn to protect multiple sclerosis drug sales
Agreement with Forward Pharma gives Biogen license to keep selling blockbuster Tecfidera
-
ResearchModel predicts graphene to melt at 6000K
Monolayer graphene could survive on the surface of the sun